中国医药(600056)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600056 中国医药

已收盘 06-02 15:00:00

{"stockData":{"symbol":"600056","market":"SH","secType":"STK","nameCN":"中国医药","latestPrice":13.71,"timestamp":1685689200000,"preClose":13.67,"halted":0,"volume":15418728,"delay":0,"floatShares":1495000000,"shares":1496000000,"eps":0.5071,"marketStatus":"已收盘","marketStatusCode":5,"change":0.04,"latestTime":"06-02 15:00:00","open":13.62,"high":13.73,"low":13.58,"amount":211000000,"amplitude":0.011,"askPrice":13.72,"askSize":1089,"bidPrice":13.71,"bidSize":1918,"shortable":0,"etf":0,"ttmEps":0.5071,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1685928600000},"adr":0,"adjPreClose":13.67,"symbolType":"stock","highLimit":15.04,"lowLimit":12.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1495879748,"pbRate":1.85,"roa":"--","roe":"2.45%","epsLYR":0.4918,"committee":0.130389,"marketValue":20509000000,"floatMarketCap":20501000000,"peRate":27.036088,"changeRate":0.0029,"turnoverRate":0.0103,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2023-06-05。"},"requestUrl":"/m/hq/s/600056/wiki","defaultTab":"wiki","newsList":[{"id":"2338083157","title":"36氪研究院｜2023年中国医药培养基行业洞察报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2338083157","media":"36氪","top":-1,"share":"https://www.laohu8.com/m/news/2338083157?lang=zh_CN&edition=full","pubTime":"2023-05-25 16:02","pubTimestamp":1685001753,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052516051183d7741e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023052516051183d7741e&s=b","is_publish_highlight":false},{"id":"2335514866","title":"2022年中国医药商业上市公司净利润排行榜（附全榜单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2335514866","media":"中商情报网","top":-1,"share":"https://www.laohu8.com/m/news/2335514866?lang=zh_CN&edition=full","pubTime":"2023-05-15 18:32","pubTimestamp":1684146760,"startTime":"0","endTime":"0","summary":"中商情报网讯：近期，医药商业上市公司陆续发布了2022年年报，21家公司净利润超万亿元，6家公司净利润超10万亿元。上海医药净利润最高达561715.2亿元，九州通、国药股份排名第二和第三，净利润分别为208496.25亿元、196405.76亿元。益丰药房、大参林、一心堂、重药控股、老百姓、中国医药、柳药集团进入前十，依次排名第4-10名。数据来源：中商产业研究院大数据库","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051518344183bcf275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051518344183bcf275&s=b","is_publish_highlight":false},{"id":"2334135970","title":"中国医药：拟发行GDR并申请在瑞交所挂牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2334135970","media":"E公司","top":-1,"share":"https://www.laohu8.com/m/news/2334135970?lang=zh_CN&edition=full","pubTime":"2023-05-12 20:53","pubTimestamp":1683895980,"startTime":"0","endTime":"0","summary":"e公司讯，中国医药(600056)5月12日晚间公告，公司拟发行全球存托凭证(GDR)，并申请在瑞士证券交易所挂牌上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305122053418065312e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305122053418065312e&s=b","is_publish_highlight":false},{"id":"2334582090","title":"中国医药(600056.SH)：拟发行全球存托凭证并申请在瑞士证券交易所上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2334582090","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2334582090?lang=zh_CN&edition=full","pubTime":"2023-05-12 20:27","pubTimestamp":1683894431,"startTime":"0","endTime":"0","summary":"格隆汇5月12日丨中国医药(600056.SH)公布，公司拟发行全球存托凭证(GDR)，并申请在瑞士证券交易所挂牌上市，GDR以公司新增发行的人民币普通股A股作为基础证券。为完成本次发行上市，公司拟根据相关法律法规的规定转为境外募集股份有限公司，并根据GDR招股说明书所载条款及条件，向符合相关条件的投资者发行GDR。公司发行的GDR在存续期内的数量上限按照发行前确定的GDR与基础证券A股股票的转换率及作为GDR基础证券的A股股票数量计算确定，前述A股股票数量不超过公司本次发行上市完成前普通股总股本的10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230512202714821130a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230512202714821130a4&s=b","is_publish_highlight":false},{"id":"2334200262","title":"中国医药5月9日获融资净买入1786万元 环比增加1113.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2334200262","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2334200262?lang=zh_CN&edition=full","pubTime":"2023-05-10 10:01","pubTimestamp":1683684070,"startTime":"0","endTime":"0","summary":"5月9日，中国医药获融资净买入1786万元，环比上一交易日增加1113.30%。其中，融资买入1.27亿元，融资偿还1.09亿元。融券方面，融券卖出103.41万股，当前融券余量为184.40万股。A股市场共有2342股获融资净买入，中国医药净买入额排名第132。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305101001178064f027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305101001178064f027&s=b","is_publish_highlight":false},{"id":"2330525074","title":"图解中国医药一季报：第一季度单季净利润同比增9.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2330525074","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2330525074?lang=zh_CN&edition=full","pubTime":"2023-04-28 19:52","pubTimestamp":1682682774,"startTime":"0","endTime":"0","summary":"中国医药2023一季报显示，公司主营收入125.31亿元，同比上升47.08%；归母净利润2.69亿元，同比上升9.27%；扣非净利润2.52亿元，同比上升16.81%；负债率65.05%，投资收益1530.3万元，财务费用4324.15万元，毛利率9.84%。证券之星力求但不保证该信息全部或者部分内容的的准确性、完整性、有效性、及时性等，如存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023042800040285.shtml","is_publish_highlight":false},{"id":"2330544436","title":"中国医药(600056.SH)发2022年度业绩，净利润7.36亿元，同比增长13.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2330544436","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2330544436?lang=zh_CN&edition=full","pubTime":"2023-04-28 18:27","pubTimestamp":1682677622,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国医药(600056.SH)发布2022年年度报告，营业收入375.93亿元，同比增长3.75%。归属于上市公司股东的净利润7.36亿元，同比增长13.70%。归属于上市公司股东的扣除非经常性损益的净利润6亿元，同比增长2.56%。基本每股收益0.4918元，公司拟向全体股东每10股派发现金红利1.4755元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/923685.html","is_publish_highlight":false},{"id":"2330554156","title":"中国医药(600056.SH)一季度扣非净利润2.52亿元、同比增长16.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2330554156","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2330554156?lang=zh_CN&edition=full","pubTime":"2023-04-28 17:43","pubTimestamp":1682674981,"startTime":"0","endTime":"0","summary":"格隆汇4月28日丨中国医药(600056.SH)发布2023年第一季度报告，实现营业收入125.31亿元，同比增长47.08%；归属于上市公司股东的净利润2.69亿元，同比增长9.27%；归属于上市公司股东的扣除非经常性损益的净利润2.52亿元，同比增长16.81%；基本每股收益0.1797元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023042817430781f0e65d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023042817430781f0e65d&s=b","is_publish_highlight":false},{"id":"2330203845","title":"中国医药(600056.SH)子公司注射用盐酸多西环素通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2330203845","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2330203845?lang=zh_CN&edition=full","pubTime":"2023-04-25 16:02","pubTimestamp":1682409722,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国医药(600056.SH)发布公告，近日，公司下属子公司海南通用康力制药有限公司(简称“康力药业”)收到国家药品监督管理局(简称“国家药监局”)核准签发的一份注射用盐酸多西环素《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。注射用盐酸多西环素为四环素类抗生素，适用于多种微生物、革兰氏阴性菌、革兰氏阳性菌引起的感染。截至本公告披露日，该药品一致性评价研发投入约588万元人民币(未经审计)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/917634.html","is_publish_highlight":false},{"id":"2329770981","title":"中国医药(600056.SH)聘任葛晓红任总会计师","url":"https://stock-news.laohu8.com/highlight/detail?id=2329770981","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2329770981?lang=zh_CN&edition=full","pubTime":"2023-04-21 16:56","pubTimestamp":1682067360,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国医药(600056.SH)公告，公司总会计师郭毓轶因工作调整原因，郭毓轶申请辞去公司总会计师职务，并不再担任公司任何职务。董事会聘任葛晓红任公司总会计师，任期自董事会决议通过日至第九届董事会届满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/915051.html","is_publish_highlight":false},{"id":"2328381213","title":"中国医药：董事车凌云辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2328381213","media":"每经网","top":-1,"share":"https://www.laohu8.com/m/news/2328381213?lang=zh_CN&edition=full","pubTime":"2023-04-18 20:39","pubTimestamp":1681821588,"startTime":"0","endTime":"0","summary":"中国医药 4月18日晚间发布公告称，因工作调整，车凌云先生申请辞去公司第九届董事会董事及专门委员会委员相关职务，并不再担任公司任何职务。2022年1至6月份，中国医药的营业收入构成为：医药商业占比71.45%，医药贸易占比20.49%，化学制剂占比5.74%， 原料药 占比2.43%，中成药占比1.43%。中国医药的董事长是李亚东，男，学历背景为硕士；总经理是胡慧冬，女，48岁，学历背景为硕士。截至发稿，中国医药市值为205亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202304182049418426c044&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202304182049418426c044&s=b","is_publish_highlight":false},{"id":"2323774076","title":"中国医药3月30日获北向资金加仓342.40万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2323774076","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2323774076?lang=zh_CN&edition=full","pubTime":"2023-03-31 09:30","pubTimestamp":1680226225,"startTime":"0","endTime":"0","summary":"3月30日, 北向资金增持中国医药342.40万股。截止当日收盘，沪股通共持有中国医药2127.73万股，占流通股1.42%。沪股通增持金额前五个股分别为兆易创新、中国石油、贵州茅台、伊利股份、中国神华。中国医药近5个交易日下跌3.75%，沪股通累计增持150.00万股；近20个交易日下跌13.15%，沪股通累计增持245.92万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230331093049806205d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230331093049806205d2&s=b","is_publish_highlight":false},{"id":"2323193937","title":"复宏汉霖携多款重磅医药产品领先成果亮相中国医药创新与投资大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2323193937","media":"复宏汉霖","top":-1,"share":"https://www.laohu8.com/m/news/2323193937?lang=zh_CN&edition=full","pubTime":"2023-03-30 18:07","pubTimestamp":1680170852,"startTime":"0","endTime":"0","summary":"3月29日，由中国医药创新促进会发起的中国医药创新与投资大会（简称“创投大会”）在苏州拉开帷幕，复宏汉霖携多款重磅创新生物药产品领先成果亮相，并受邀出席“临床研究与医药创新合作论 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20230330/c646046690.shtml","is_publish_highlight":false},{"id":"2323200887","title":"中国医药：子公司注射用头孢噻肟钠等产品拟中标第八批全国药品集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2323200887","media":"E公司","top":-1,"share":"https://www.laohu8.com/m/news/2323200887?lang=zh_CN&edition=full","pubTime":"2023-03-29 23:11","pubTimestamp":1680102660,"startTime":"0","endTime":"0","summary":"e公司讯，中国医药(600056)3月29日晚间公告，公司下属子公司三洋药业通过仿制药质量和疗效一致性评价的产品注射用哌拉西林钠他唑巴坦钠、注射用头孢噻肟钠、醋酸阿托西班注射液拟中标第八批全国药品集中采购。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023032923115783579812&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023032923115783579812&s=b","is_publish_highlight":false},{"id":"2321641170","title":"艾迪药业(688488.SH)与中国医药保健品有限公司签订《合作框架协议》","url":"https://stock-news.laohu8.com/highlight/detail?id=2321641170","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2321641170?lang=zh_CN&edition=full","pubTime":"2023-03-21 18:18","pubTimestamp":1679393902,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾迪药业 发布公告，公司与中国医药保健品有限公司经友好协商，达成合作意向并于近日签订了《合作框架协议》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/895728.html","is_publish_highlight":false},{"id":"2320522209","title":"中国医药产业的“可计算”革命","url":"https://stock-news.laohu8.com/highlight/detail?id=2320522209","media":"锦缎","top":-1,"share":"https://www.laohu8.com/m/news/2320522209?lang=zh_CN&edition=full","pubTime":"2023-03-20 07:59","pubTimestamp":1679270351,"startTime":"0","endTime":"0","summary":"比如本文将深入透视的发生在我国医疗、医药产业的这场深入变革，一定程度上，正是“可计算”逻辑的表彰——它就是：DRG。作为中国医药产业支付的兜底者，医保局实则是中国医药市场的最大客户。经过分析，我们认为这股无形的力量将会推动中国医药产业出现5个趋势性的变化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fenghuang_stock","url":"https://tech.ifeng.com/c/8OIfTXaC988","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8OIfTXaC988","is_publish_highlight":false},{"id":"2319335242","title":"雅本化学：公司与中国医药无供货关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2319335242","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2319335242?lang=zh_CN&edition=full","pubTime":"2023-03-16 16:47","pubTimestamp":1678956449,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：贵司与中国医药有供货关系吗？雅本化学（300261.SZ）3月16日在投资者互动平台表示，公司与中国医药无供货关系。(记者 姚祥云)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230316164815826bc277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230316164815826bc277&s=b","is_publish_highlight":false},{"id":"2317408756","title":"研发投入856万元 中国医药注射用特利加压素获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2317408756","media":"新京报","top":-1,"share":"https://www.laohu8.com/m/news/2317408756?lang=zh_CN&edition=full","pubTime":"2023-03-08 17:18","pubTimestamp":1678267119,"startTime":"0","endTime":"0","summary":"pan>收到《药品注册证书》，获批上市。pan>pan>适用于胃肠道、泌尿生殖系统、术后出血的治疗以及妇科手术的局部应用、肝肾综合征、肝移植患者术前术后肝肾综合征的治疗或预防等和顽固性（对儿茶酚胺抵抗性）休克等治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303081720238267e182&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202303081720238267e182&s=b","is_publish_highlight":false},{"id":"2317546873","title":"中国医药(600056.SH)子公司获得注射用特利加压素药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2317546873","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2317546873?lang=zh_CN&edition=full","pubTime":"2023-03-07 17:43","pubTimestamp":1678182195,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国医药 发布公告，近日，公司下属全资子公司通用三洋收到国家药监局核准签发的一份注射用特利加压素《药品注册证书》。根据米内网数据库国内市场样本医院用药销售统计显示，2021年注射用特利加压素样本医院销售额约为2.34亿元，2022年上半年销售额约为1.29亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/887968.html","is_publish_highlight":false},{"id":"2317463439","title":"中国医药：子公司注射用特利加压素获得药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2317463439","media":"财通社","top":-1,"share":"https://www.laohu8.com/m/news/2317463439?lang=zh_CN&edition=full","pubTime":"2023-03-07 17:42","pubTimestamp":1678182120,"startTime":"0","endTime":"0","summary":"【中国医药：子公司注射用特利加压素获得药品注册批件】中国医药公告，子公司注射用特利加压素获得药品注册批件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030717425982674325&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023030717425982674325&s=b","is_publish_highlight":false}],"profile":{"ret":0,"listingDate":"1997-05-15","address":"北京市丰台区西营街1号院1区1号楼25-28层","stockEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0365},{"period":"3month","weight":-0.1273},{"period":"6month","weight":-0.1484},{"period":"1year","weight":-0.0093},{"period":"ytd","weight":-0.2043}],"companyName":"中国医药健康产业股份有限公司","boardCode":"AI0051","perCapita":"7125股","boardName":"批发业","registeredCapital":"149587万元","compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":-0.028},{"period":"3month","weight":-0.0295},{"period":"6month","weight":0.0234},{"period":"1year","weight":0.0108},{"period":"ytd","weight":0.0456}],"survey":"　　中国医药健康产业股份有限公司建立了以国际贸易为引领、以医药工业为支撑、以医药商业为纽带的贸、工、技、服一体化产业格局，全面推动工商贸三大业务板块业务整合，积极发挥协同优势。主要产品有原料药、制剂药、中成药、医药商业、国际贸易。从最新公布的权威行业排名显示，公司位列2020年度中国医药工业百强榜化药企业排名第35位；中国医药-重庆医药联合体位列2020年医药流通百强第5位。","serverTime":1685775814976,"listedPrice":7.02,"stockholders":"209873人(较上一季度减少5.36%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.13.0","shortVersion":"4.13.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国医药(600056)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国医药(600056)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国医药,600056,中国医药股票,中国医药股票老虎,中国医药股票老虎国际,中国医药行情,中国医药股票行情,中国医药股价,中国医药股市,中国医药股票价格,中国医药股票交易,中国医药股票购买,中国医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国医药(600056)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国医药(600056)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}